138 related articles for article (PubMed ID: 21161325)
1. Letter to the editor: "Phase II trial of S-1 monotherapy in elderly or frail patients with metastatic colorectal cancer".
Molina-Garrido MJ; Guillén-Ponce C
Invest New Drugs; 2011 Dec; 29(6):1515-6. PubMed ID: 21161325
[No Abstract] [Full Text] [Related]
2. Phase II trial of S-1 monotherapy in elderly or frail patients with metastatic colorectal cancer.
Shin SJ; Jeong JH; Park YS; Lee KH; Shim BY; Kim TW; Oh DY; Lee MA; Kim YT; Kim YH; Zang DY; Roh JK; Ahn JB
Invest New Drugs; 2011 Oct; 29(5):1073-80. PubMed ID: 20306116
[TBL] [Abstract][Full Text] [Related]
3. First-line treatment of patients with metastatic pancreatic cancer: results of a Phase II trial with S-1 (CESAR-Study group).
Strumberg D; Bergmann L; Graeven U; Hanauske A; Lipp R; Schuette J; Schultheis B; Scigalla P; Urrea P; Scheulen ME
Int J Clin Pharmacol Ther; 2010 Jul; 48(7):470-2. PubMed ID: 20557848
[No Abstract] [Full Text] [Related]
4. Capecitabine versus S-1 as adjuvant chemotherapy for patients with stage III colorectal cancer (JCOG0910): an open-label, non-inferiority, randomised, phase 3, multicentre trial.
Hamaguchi T; Shimada Y; Mizusawa J; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Takiguchi N; Yatsuoka T; Takii Y; Ojima H; Masuko H; Kubo Y; Mishima H; Yamaguchi T; Bando H; Sato T; Kato T; Nakamura K; Fukuda H; Moriya Y
Lancet Gastroenterol Hepatol; 2018 Jan; 3(1):47-56. PubMed ID: 29079411
[TBL] [Abstract][Full Text] [Related]
5. Letter to the editor: 5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer.
Kim HD; Ryu MH; Lee JS; Kang YK
Gastric Cancer; 2024 Jul; 27(4):884-885. PubMed ID: 38602609
[No Abstract] [Full Text] [Related]
6. Phase II trial of adjuvant chemotherapy with S-1 for colorectal liver metastasis.
Uehara K; Maeda A; Sakamoto E; Hiramatsu K; Takeuchi E; Sakaguchi K; Tojima Y; Takahashi Y; Ebata T; Nagino M
Ann Surg Oncol; 2013 Feb; 20(2):475-81. PubMed ID: 22965575
[TBL] [Abstract][Full Text] [Related]
7. Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil and oteracil potassium) for colorectal cancer.
Kawahara H; Watanabe K; Ushigome T; Noaki R; Kobayashi S; Yanaga K
Hepatogastroenterology; 2012; 59(113):134-7. PubMed ID: 22251528
[TBL] [Abstract][Full Text] [Related]
8. The role of S-1 in the treatment of gastric cancer.
Kubota T
Br J Cancer; 2008 Apr; 98(8):1301-4. PubMed ID: 18362933
[TBL] [Abstract][Full Text] [Related]
9. EORTC Early Clinical Studies Group early phase II trial of S-1 in patients with advanced or metastatic colorectal cancer.
Van den Brande J; Schöffski P; Schellens JH; Roth AD; Duffaud F; Weigang-Köhler K; Reinke F; Wanders J; de Boer RF; Vermorken JB; Fumoleau P
Br J Cancer; 2003 Mar; 88(5):648-53. PubMed ID: 12659110
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of S-1, a novel oral fluorophyrimidine derivative, in patients with metastatic colorectal carcinoma. S-1 Cooperative Colorectal Carcinoma Study Group.
Ohtsu A; Baba H; Sakata Y; Mitachi Y; Horikoshi N; Sugimachi K; Taguchi T
Br J Cancer; 2000 Jul; 83(2):141-5. PubMed ID: 10901361
[TBL] [Abstract][Full Text] [Related]
11. Oral fluoropyrimidines in colorectal cancer.
Van Cutsem E; Peeters M
Semin Oncol; 2000 Oct; 27(5 Suppl 10):91-5. PubMed ID: 11049039
[No Abstract] [Full Text] [Related]
12. A phase I trial of S-1 with oxaliplatin in patients with relapsed and metastatic colorectal cancer.
Kim HS; Park MJ; Uhm JE; Lee Y; Lee HY; Kang EM; Lee J; Park SH; Park JO; Lim HY; Kang WK; Park YS
Int J Colorectal Dis; 2009 Nov; 24(11):1311-6. PubMed ID: 19609538
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of oral S-1 for treatment of metastatic colorectal carcinoma.
Shirao K; Ohtsu A; Takada H; Mitachi Y; Hirakawa K; Horikoshi N; Okamura T; Hirata K; Saitoh S; Isomoto H; Satoh A
Cancer; 2004 Jun; 100(11):2355-61. PubMed ID: 15160338
[TBL] [Abstract][Full Text] [Related]
14. S-1 induced a durable response in metastatic extramammary Paget's disease.
Mikoshiba Y; Uhara H; Kubo H; Okuyama R
J Dermatol; 2013 Aug; 40(8):664-5. PubMed ID: 23682853
[No Abstract] [Full Text] [Related]
15. Phase II multicenter study of adjuvant S-1 for colorectal liver metastasis: survival analysis of N-SOG 01 trial.
Kato T; Uehara K; Maeda A; Sakamoto E; Hiramatsu K; Takeuchi E; Goto H; Tojima Y; Yatsuya H; Nagino M;
Cancer Chemother Pharmacol; 2015 Jun; 75(6):1281-8. PubMed ID: 25929347
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of S-1 monotherapy in patients over 75 years of age with advanced gastric cancer (OGSG0404).
Imamura H; Kishimoto T; Takiuchi H; Kimura Y; Morimoto T; Imano M; Iijima S; Yamashita K; Maruyama K; Otsuji T; Kurokawa Y; Furukawa H
J Chemother; 2014 Feb; 26(1):57-61. PubMed ID: 24090674
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of S-1 monotherapy as a first-line treatment for elderly patients with advanced nonsmall-cell lung cancer: the Central Japan Lung Study Group trial 0404.
Nishiyama O; Taniguchi H; Kondoh Y; Takada K; Baba K; Saito H; Sugino Y; Yamamoto M; Ogasawara T; Kondo M; Imaizumi K; Hasegawa Y; Suzuki R; Shimokata K;
Anticancer Drugs; 2011 Sep; 22(8):811-6. PubMed ID: 21317767
[TBL] [Abstract][Full Text] [Related]
18. [Not Available].
Zentralbl Chir; 2019 Dec; 144(6):519. PubMed ID: 31826287
[No Abstract] [Full Text] [Related]
19. Effect of S-1 adjuvant chemotherapy on survival following recurrence and efficacy of first-line treatment in recurrent gastric cancer.
Hasegawa H; Fujitani K; Kurokawa Y; Hirao M; Nakazuru S; Mita E; Tsujinaka T
Chemotherapy; 2010; 56(6):436-43. PubMed ID: 21088394
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of combination therapy with S-1 and irinotecan in patients with advanced colorectal cancer.
Goto A; Yamada Y; Yasui H; Kato K; Hamaguchi T; Muro K; Shimada Y; Shirao K
Ann Oncol; 2006 Jun; 17(6):968-73. PubMed ID: 16603600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
